Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Advance in biologics for chronic rhinosinusitis with nasal polyps
View through CrossRef
Managing chronic rhinosinusitis with nasal polyps (CRSwNP) poses challenges, especially when conventional treatments fail to achieve adequate symptom control. CRSwNP is often marked by type 2 inflammation, and a large number of patients have other comorbid type 2 conditions, such as asthma. Currently, 4 biologics have been approved to treat CRSwNP—dupilumab, omalizumab, mepolizumab, and stapokibart (stapokibart is approved in China but not by the US Food and Drug Administration)—with additional promising therapies currently under development. Biologics can enhance the quality of life for CRSwNP patients, reduce the need for systemic corticosteroid therapy and endoscopic sinus surgery (ESS), and improve the management of comorbid conditions. We review clinical trials and real-world data on the effectiveness and safety of biologics for CRSwNP, compare biologic therapy and ESS, and explore the switching and simultaneous use of biologics.
Title: Advance in biologics for chronic rhinosinusitis with nasal polyps
Description:
Managing chronic rhinosinusitis with nasal polyps (CRSwNP) poses challenges, especially when conventional treatments fail to achieve adequate symptom control.
CRSwNP is often marked by type 2 inflammation, and a large number of patients have other comorbid type 2 conditions, such as asthma.
Currently, 4 biologics have been approved to treat CRSwNP—dupilumab, omalizumab, mepolizumab, and stapokibart (stapokibart is approved in China but not by the US Food and Drug Administration)—with additional promising therapies currently under development.
Biologics can enhance the quality of life for CRSwNP patients, reduce the need for systemic corticosteroid therapy and endoscopic sinus surgery (ESS), and improve the management of comorbid conditions.
We review clinical trials and real-world data on the effectiveness and safety of biologics for CRSwNP, compare biologic therapy and ESS, and explore the switching and simultaneous use of biologics.
Related Results
BIOLOGICAL THERAPY IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS: A LITERATURE REVIEW OF TREATMENT METHODS INCLUDING DUPILUMAB AND MEPOLIZUMAB
BIOLOGICAL THERAPY IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS: A LITERATURE REVIEW OF TREATMENT METHODS INCLUDING DUPILUMAB AND MEPOLIZUMAB
Introduction and purpose: Nasal polyps occur in chronic mucosal inflammation of the nasal cavity. Overgrown mucosa forms pale colored, smooth, lobular, poorly vascularized structur...
The Correlation of Peripheral Blood Eosinophils with Allergic Nasal Polyps
The Correlation of Peripheral Blood Eosinophils with Allergic Nasal Polyps
Aim: To observe the association of peripheral blood eosinophil percentage in patients with allergic nasal polyps. Design: Descriptive cross-sectional study Place and duration: Path...
Interleukin-5 Levels in Chronic Rhinosinusitis Patients With and Without Allergy
Interleukin-5 Levels in Chronic Rhinosinusitis Patients With and Without Allergy
<b>Introduction:</b> Chronic rhinosinusitis (CRS) is an inflammation of the nasal mucosa and paranasal sinuses that is present for more than 12 weeks. The pathogenesis ...
Association of breathing patterns and quality of life in
patients with nasal obstruction
Association of breathing patterns and quality of life in
patients with nasal obstruction
Introduction: In the general population, nasal obstruction is a common complaint. However, an objective evaluation
of nasal obstruction is difficult. Nose examination, computed tom...
Epithelial gastric polyps
Epithelial gastric polyps
Gastric polyps are lesions projected above the mucosal surface, which are detected in approximately 1–6% of upper gastrointestinal endoscopies. Based to their shape, polyps are cla...
MONITORING OF CHRONIC SINUSITIS USING NASAL NITRIC OXIDE AS A MARKER OF SINUS HEALTH: A SYSTEMATIC REVIEW
MONITORING OF CHRONIC SINUSITIS USING NASAL NITRIC OXIDE AS A MARKER OF SINUS HEALTH: A SYSTEMATIC REVIEW
It was reported that, nasal nitric oxide (nNO) is continuously released in the paranasal sinuses which acts as antibacterial and antiviral agent and improves mucociliary clearance ...
Nasal and Intravenous Administration of Dexmedetomidine to Prevent the Emergence Agitation After the Vascular Interventional Surgery in Children: A Randomized, Double-blind, Controlled Study
Nasal and Intravenous Administration of Dexmedetomidine to Prevent the Emergence Agitation After the Vascular Interventional Surgery in Children: A Randomized, Double-blind, Controlled Study
Abstract
Introduction: Dexmedetomidine reduces the incidences of postanesthetic restlessness and hemodynamic fluctuations in children within acceptable ranges. Dexmedetomid...
The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients
The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients
Although there is a strong correlation between oral/oro-nasal breathing and apnoea/hypopnoea index in patients with obstructive sleep apnoea and normal nasal resistance at wakefuln...